Mainz, Germany - September 2, 2014, Mainz, Germany - BioNTech AG, a biopharmaceutical company, has announced that Sierk Pötting joined the management team of BioNTech AG as chief financial officer.
Article continues below
Mr. Pötting draws on many years of experience. After completing his degree and postdoctoral work in quantum physics, he began his career as a consultant with the company McKinsey before moving over to work with Novartis. For the past several years, Mr. Pötting has served as CFO and Vice President at Sandoz, Inc. in the USA. He is succeeding former CFO Michael Kring. ■